Deputy Division Director, OND/CDER
Associate Directory, Oncology Center of Excellence
Food and Drug Administration
Lola A. Fashoyin-Aje, MD, MPH, is a medical oncologist and Deputy Director in the Division of Oncology 3 (DO3) in the Office of Oncologic Diseases (OOD) at the Center for Drug Evaluation and Research- Food and Drug Administration (FDA). In this role, she provides scientific and policy guidance and oversight to multidisciplinary teams reviewing drugs and biologics under development for the treatment of solid tumor malignancies (gastrointestinal, cutaneous, and sarcoma). Dr. Fashoyin-Aje is also Associate Director of Scientific and Policy initiatives to address disparities in drug development in the FDA Oncology Center of Excellence (OCE). In this role, she provides direction and oversight on all scientific and policy efforts related to improving the inclusion of participants who are members of historically underrepresented demographic groups, in oncology medical product development programs. Prior to joining the FDA, Dr. Fashoyin-Aje completed her undergraduate and graduate training at Columbia University and Yale University, respectively, and received her M.D. degree from the University of Rochester School of Medicine and Dentistry. She completed her training in internal medicine and medical oncology at Johns Hopkins.
Disclosure information not submitted.
Tuesday, September 13, 2022
9:45 AM – 11:00 AM MST